Tofacitinib for treating active ankylosing spondylitis

Equality Impact Assessment (Guidance development) (PDF 144 KB)

Final draft guidance

Final draft guidance (PDF 208 KB)

Committee papers (PDF 5.15 MB)

Final scope (PDF 313 KB)

Final stakeholder list (PDF 178 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 288 KB)

Draft scope post referral (PDF 211 KB)